{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:22:21Z","timestamp":1791400941417,"version":"4.3.3"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100003980","name":"National Eczema Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009655","name":"Sunovion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011944","name":"School of Public Health, University of California Berkeley","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011944","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005565","name":"Janssen Biotech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005620","name":"North Carolina GlaxoSmithKline Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014122","name":"Asthma and Allergy Foundation of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014122","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jaip.2019.05.055","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T04:06:19Z","timestamp":1561003579000},"page":"2699-2706.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["Pain Is a Common and Burdensome Symptom of Atopic Dermatitis in United States Adults"],"prefix":"10.1016","volume":"7","author":[{"given":"Jonathan I.","family":"Silverberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Gelfand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Boguniewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz","family":"Fonacier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell H.","family":"Grayson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelma C.","family":"Chiesa Fuxench","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peck Y.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2019.05.055_bib1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jid.2018.08.028","article-title":"Atopic Dermatitis in America Study: a cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the US adult population","volume":"139","author":"Chiesa Fuxench","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2019.05.055_bib2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.anai.2018.07.006","article-title":"Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study","volume":"121","author":"Silverberg","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.05.055_bib3","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jaip.2018.11.043","article-title":"Health utility scores of atopic dermatitis in US adults","volume":"7","author":"Silverberg","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.05.055_bib4","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.anai.2018.07.042","article-title":"Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adults","volume":"121","author":"Silverberg","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.05.055_bib5","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1038\/jid.2015.337","article-title":"Association between atopic dermatitis and depression in US adults","volume":"135","author":"Yu","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2019.05.055_bib6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.clindermatol.2017.03.008","article-title":"Selected comorbidities of atopic dermatitis: atopy, neuropsychiatric, and musculoskeletal disorders","volume":"35","author":"Silverberg","year":"2017","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaip.2019.05.055_bib7","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.anai.2017.09.076","article-title":"Burden of skin pain in atopic dermatitis","volume":"119","author":"Vakharia","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.05.055_bib8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaad.2015.10.043","article-title":"Patient burden of moderate to severe atopic dermatitis (AD): insights from a phase 2b clinical trial of dupilumab in adults","volume":"74","author":"Simpson","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2019.05.055_bib9","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2133.1994.tb08532.x","article-title":"The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis: III. Independent hospital validation","volume":"131","author":"Williams","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2019.05.055_bib10","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1398-9995.2011.02577.x","article-title":"Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe","volume":"66","author":"Stalder","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.05.055_bib11","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/bjd.12590","article-title":"Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods","volume":"169","author":"Charman","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2019.05.055_bib12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)\u2014a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2019.05.055_bib13","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/bjd.15179","article-title":"Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement","volume":"176","author":"Spuls","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2019.05.055_bib14","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1111\/bjd.16543","article-title":"Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema\/dermatitis clinical trials (HOME initiative)","volume":"178","author":"Chalmers","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2019.05.055_bib15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/all.13309","article-title":"Validation of patient-reported global severity of atopic dermatitis in adults","volume":"73","author":"Vakharia","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.05.055_bib16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.anai.2018.07.040","article-title":"Content and construct validity, predictors, and distribution of self-reported atopic dermatitis severity in US adults","volume":"121","author":"Silverberg","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.05.055_bib17","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.anai.2018.07.004","article-title":"Severity strata for POEM, PO-SCORAD, and DLQI in US adults with atopic dermatitis","volume":"121","author":"Silverberg","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.05.055_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate\u2014a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J\u00a0R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/j.jaip.2019.05.055_bib19","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1097\/j.pain.0000000000000980","article-title":"Nonhistaminergic and mechanical itch sensitization in atopic dermatitis","volume":"158","author":"Andersen","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.jaip.2019.05.055_bib20","first-page":"629","article-title":"Racial-ethnic differences in osteoarthritis pain and disability: a meta-analysis","volume":"20","author":"Vaughn","year":"2019","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.jaip.2019.05.055_bib21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s10865-008-9192-1","article-title":"Disparities in the provision of medical care: an outcome in search of an explanation","volume":"32","author":"Klonoff","year":"2009","journal-title":"J\u00a0Behav Med"},{"key":"10.1016\/j.jaip.2019.05.055_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1526-4637.2003.03034.x","article-title":"The unequal burden of pain: confronting racial and ethnic disparities in pain","volume":"4","author":"Green","year":"2003","journal-title":"Pain Med"},{"key":"10.1016\/j.jaip.2019.05.055_bib23","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1046\/j.1365-2133.1999.03112.x","article-title":"Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensitivity to change of the DLQI. The Cavide Research Group","volume":"141","author":"Badia","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2019.05.055_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000365075","article-title":"Analysis of correlations between patient-oriented SCORAD (PO-SCORAD) and other assessment scores of atopic dermatitis severity and quality of life","volume":"229","author":"Coutanceau","year":"2014","journal-title":"Dermatology"},{"key":"10.1016\/j.jaip.2019.05.055_bib25","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2133.2005.07050.x","article-title":"Life quality assessment among patients with atopic eczema","volume":"154","author":"Holm","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2019.05.055_bib26","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1046\/j.1365-2133.1997.d01-1225.x","article-title":"Measurement of quality of life in atopic dermatitis: correlation and validation of two different methods","volume":"136","author":"Herd","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2019.05.055_bib27","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1046\/j.1365-4362.2000.00073.x","article-title":"The effect of skin diseases on quality of life in patients from different social and ethnic groups in Cape Town, South Africa","volume":"39","author":"Jobanputra","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaip.2019.05.055_bib28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1550-8579(04)80017-2","article-title":"Does visible atopic dermatitis affect quality of life more in women than in men?","volume":"1","author":"Holm","year":"2004","journal-title":"Gend Med"},{"key":"10.1016\/j.jaip.2019.05.055_bib29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/jid.2011.238","article-title":"Can we rely on the Dermatology Life Quality Index as a measure of the impact of psoriasis or atopic dermatitis?","volume":"132","author":"Twiss","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2019.05.055_bib30","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/bjd.13237","article-title":"Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema\/dermatitis clinical trials (HOME)","volume":"171","author":"Chalmers","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2019.05.055_bib31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/bjd.14773","article-title":"Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema\/dermatitis clinical trials (HOME initiative)","volume":"175","author":"Chalmers","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2019.05.055_bib32","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/bjd.14588","article-title":"Reporting of symptoms in randomized controlled trials of atopic eczema treatments: a systematic review","volume":"175","author":"Gerbens","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2019.05.055_bib33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/all.12959","article-title":"Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review","volume":"72","author":"Gerbens","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.05.055_bib34","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2340\/00015555-2322","article-title":"Eczema trials: quality of life instruments used and their relation to patient-reported outcomes. A systematic review","volume":"96","author":"Heinl","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2019.05.055_bib35","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/all.12806","article-title":"Measurement properties of adult quality-of-life measurement instruments for eczema: a systematic review","volume":"71","author":"Heinl","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.05.055_bib36","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/bjd.14966","article-title":"Measurement properties of quality-of-life measurement instruments for infants, children and adolescents with eczema: a systematic review","volume":"176","author":"Heinl","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2019.05.055_bib37","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1365-2133.2010.10054.x","article-title":"Harmonising Outcome Measures for Eczema (HOME). Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany","volume":"163","author":"Schmitt","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2019.05.055_bibE1","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1001\/jamadermatol.2016.2154","article-title":"Pubic hair grooming prevalence and motivation among women in the United States","volume":"152","author":"Rowen","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2019.05.055_bibE2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3758\/s13428-015-0617-9","article-title":"Use of internet panels to conduct surveys","volume":"47","author":"Hays","year":"2015","journal-title":"Behav Res Methods"},{"key":"10.1016\/j.jaip.2019.05.055_bibE3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamadermatol.2013.515","article-title":"Correspondence and correlates of couples' skin cancer screening","volume":"149","author":"Heckman","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2019.05.055_bibE4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2307\/2983403","article-title":"Evaluation of methods for ecological inference","volume":"158","author":"Cleave","year":"1995","journal-title":"J\u00a0R Stat Soc Ser A Stat Soc"},{"key":"10.1016\/j.jaip.2019.05.055_bibE5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/0953531042000219259","article-title":"Biproportional techniques in input-output analysis: table updating and structural analysis AU\u2014Lahr, Michael","volume":"16","author":"de Mesnard","year":"2004","journal-title":"Econ Syst Res"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219819305550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219819305550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:18:28Z","timestamp":1761974308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219819305550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S2213219819305550"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2019.05.055","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pain Is a Common and Burdensome Symptom of Atopic Dermatitis in United States Adults","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2019.05.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}